Member Info for TrekMadone

“World Health Organization continues to highlight the need for the prioritization of personal protective equipment supplies for frontline healthcare workers and graphene could be used as coatings of facemasks to minimize the risk of transmission. Graphene textile applications for epidemiological exposure detection and for filtering are possible allies of health systems against pandemic spreading. Furthermore, high-throughput diagnostics and drug screening based on graphene sensors have been successfully demonstrated and some of these sensors have begun to make their way to the market place [3]. In response to this global outbreak, we have summarized the current state of knowledge of graphene-virus interaction as well as possible graphene uses transferrable to COVID-19 diagnosis and treatment. Further research is undoubtedly required but we foresee that graphene may have a leading role in the world fight against COVID-19.“

https://www.sciencedirect.com/science/article/pii/S1748013220300529?via%3Dihub

So technologically feasible...There are others in the market. Could do with our update please Directa!

Trek

Interesting

“. Patrick Frantz, Founder & CEO of planarTECH stated: "We’re really excited to be working with IDEATI again to bring another one if its innovative 2AM products to market. I have previously published on the possible use of graphene in the fight against the current COVID-19 pandemic, and while this product does not claim to address this problem, IDEATI is currently evaluating its antiviral properties. In the meantime, we believe that this product has merit for its antibacterial and antistatic properties and have decided work with IDEATI to release it into the market.”

https://www.graphene-info.com/planartech-and-ideati-launch-graphene-enhanced-antibacterial-face-masks

Trek

Newbie et all,

I recommend that you register your name and email here. It’s a source of research as much as anything. Medusa19 will contact you when products available etc...it’s another heads up.

https://medusa19.com/

Trek

Thanks for posting that flyinghigh81, we should be using our energy to look over our shoulders..

“It’s in the bag for them:”

I will try to be objective but I cannot evidence these thoughts as not all the info is in the public domain for obvious commercial reasons.

I think Sona could well beat us to it, insofar as getting FDA first. Now here’s the but. It depends on what AVCT release next week. AS has so far over delivered. There may or may not be relevance in my earlier post about the deduction that Sona have gone elsewhere for FDA (thanks RorkesDrift for your thoughtful assistance with our thinking) . It could be that AS has grabbed the resources to be first and Sona didn’t want to wait so went to Global. We don’t know but add that to Cytiva’s concerns around temperature tolerances with LFT it may be that they have gone for a ‘softer option’. There has been quite a bit of strange info and I could be miss interpreting it but the rationale deduction is Sona are not allowing Cytiva to do FDA. Why.

I think Cytiva have prioritised AVCT LFT. They intimated that the Sona test was better suited to lab. (See my earlier posts for links). There are also two other critical factors at play here...

1. scalability. We don’t know how scalable the Sona test is, all they have said it’s antigen based. What does that mean? However, we do know (you’d have seen the vid) that the avct bead affimer tech based on a protein can be upscaled and mass produced and is stable at room temperatures, transportable etc. (We don’t know the definition of room temp though)

2. Costs. Sona use gold in in their nanorods to overcome the CTAB issues, that introduces a high cost uncontrollable element hence their test will initially retail at a little under $50 a test. That imo is too expensive for a mass population at home test. It would also add too much to airport flight tickets etc. You get the gist. AVCT test is not dependent on price of gold so there are more benefits from economies of scale and it can be mass produced and produce under licence. So an edge. But if they price it at $25 that is still imo too expensive. Sure it’ll be dear initially but to attract volume and build market entry barriers price is key. AS will know this.

So say Sona cross the line first. Don’t underestimate first mover advantage, it’s massive. They will land big contracts. Whether they can scale up and reduce price I don’t know. But if they do and they have a reliable product (Remember it’s only so far been lab tested in April) then there will be no customer allegiances if there is an equivalent or better product available at half the price with a shorter delivery lead time.

Now for Goldilocks, should avct deliver FDA before Sona. Bye bye Sona. No first mover advantage and too expensive. Avct can then keep pushing the price down and driving volume. Exclusivity, patent protected.

As for SP if Sona get fda first expect a hit but if avct follow boom, and price will prevail.

Hi RorkesDrift,

That may be the point but FDA accept EUA’s from suppliers. Look at Quidell on the bottom of the link. They have submitted own test not gone through an independent.

https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

Trek

“Re: your last point, I’ve not heard that before, why would that be?”

You wouldn’t make two FDA applications for the same thing from different sources. RorkesDrift may have a point but I thought Cytiva were doing Avacta’s FDA submission so that would negate the reason for Cytiva no doing Sona’s for them. I remember posting that Cytiva had temperature problems with the Sona test. They may of course have been resolved or Sona just gone elsewhere. It’s all speculation other than we can deduce that Cytiva are not doing Sona’s FDA. We just don’t know why but that creates space in the team to work on other projects.

Trek

20 min test for up to 300 samples. Defo useful in a care home but not sure about a doctors surgery or an airport lounge, imagine getting them mixed up! Anyways, worth looking over one’s shoulder but not a threat to avct....

“....

Trials of a new coronavirus test returning results in just 20 minutes will begin in Hampshire today
The test has been shown to be highly effective in clinical settings and will now be trialled in a number of A&E departments, GP testing hubs and care homes in Hampshire
Up to 4,000 people of all ages and backgrounds will be tested
The trial of a new, rapid coronavirus test will begin in Hampshire today.

The new test, which has been proven effective in clinical settings, does not need to be sent to a laboratory to be processed and can return results within 20 minutes.

The test will be rolled out to a number of A&E departments without access to laboratories, GP coronavirus testing hubs and care homes across Hampshire.

Receiving results on site will mean people with symptoms will be given immediate certainty as to whether or not they have the virus. This will mean they can rapidly follow advice to stay at home if they test positive, or return to work.

....”

https://www.gov.uk/government/news/trial-of-rapid-coronavirus-test-launched-in-hampshire

Trek

Not sure why Sona are leaving FDA to MRIGlobal I thought Cytiva were dealing...

“May 22, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”) is pleased to announce the engagement of MRIGlobal, a leading applied scientific research organization, to provide analytical and clinical validation studies for Sona’s COVID-19 rapid detection, point-of-care, antigen test which will be used for submission to Health Canada for regulatory approval and the FDA for Emergency Use Authorization (EUA).....”

Worth reading the link as they have some impressive orders....

https://sonanano.com/sona-nanotech-engages-mriglobal-for-covid-19-test-validation-studies/

Also interesting that the shares gone up 40% on RNS, AVCT could probably expect a much high sp rise. It’s worth adding their ticker to your google finance pf.

https://www.google.co.uk/search?safe=strict&sxsrf=ALeKk02niVeSBQIX8uyirVAvFBnolsikKg:1590838745013&q=CNSX:+SONA&stick=H4sIAAAAAAAAAONgecRowS3w8sc9YSn9SWtOXmPU5OIKzsgvd80rySypFJLmYoOyBKX4uXj10_UNDVMqLDOyC3IMeRaxcjn7BUdYKQT7-zkCALSeEx5KAAAA&sa=X&ved=2ahUKEwjYt6iSwNvpAhXnDGMBHYJZBYsQlq4CegQIARAA&biw=1024&bih=643&dpr=2

My obvious thought was have they gone elsewhere as we have jumped the queue? Nothing on Cytiva web site but then they may never of intended to use Cytiva. The only recent news from Cytiva is that they are testing their associates for cv19 and antibodies. However, you can only put in one FDA application for one thing so at least we know Cytiva are not doing Sona’s for them.

Trek

Thank you avacta for my nearly new Merc. I know it sounds austentatious but I have been driving around the same car for more than 10 years and it’s been a struggle getting stuff in it for camping etc. I have now picked up a 3 year old GLC with only 15k on the clock. It’s amazing and something I couldn’t have afforded before this. I had to sell 20% to pay for it but hey.

Anyways now fortunately I have also recovered the losses in my wife’s pension. The next slice will be to help the kids with some savings and our local Foodbank that we are both really fond of. I think it will be kind of fitting that people that have lost jobs etc due to CV get a nice donation from an investment in it.

We are very fortunate in that we just need enough, sure a few luxuries but I have no ambitions to be a millionaire. Investing has now at last becoming a hobby rather than a necessity so it will be great fun to do some good with the extras. That will indeed give us more pleasure than anything.

It’s like I say when most people do well, sure they sort themselves out but then they do good. You’ll find it’s one of the motivators for some of the top posters that share their research knowing that in some way their skills may help others.

A somewhat emotional Trek with a nice car to wash on an early Sunday morning but taking nothing for granted. ATB

Trek

Ghia,

The technical term for that view aligns with the Elliot wave theory. There is a chart for that. Lol! It usually manifests in three or five waves. A good example is bitcoin at the moment.

My concern here is the SP drip ahead of results but then I guess I have banked profits and left my 100% risk money now shoot or bust on the table then why shouldn’t others.

Make no bones about it if there is no statistical differentiation over the placebo this will tank so I am invested accordingly. I also reckon for those same reasons the SP will run up as peeps look at what read outs, drill results and other inflection points are due take their punt and sell into the news. That’s how some of AIM seems to work.

ATB whatever your investment strategies.

Trek

For those that haven’t watched it yet the OO webinar for proactive it’s is a must view for any potential or existing investors here.

I have not topped up on my research on OO as I have a very low average and am only just having a revisit. I have posted on other boards at how sceptical I am about the Oxford trial and their general vaccine test paradigm against a back drop of social distancing. The OO challenge study is imo the only sure way forward. I was very impressed by the client list and CT’s general presentation and clarity around what he was going to deliver, by when and how much it would cost and the ROI guidance.

There are many rules in investing, the first 9 are probably to protect your capital and the 10th is the ability of the BoD. This is pretty clear when you look at how CT has turned around loss making businesses that had great ideas but little focus and released their potential to now generate cash. He has also pretty ruthlessly cut out the underperformance but rewarded those that have delivered. The fact that he will not helicopter in talent and trusts in the team’s succession planning is a testament to those people that are delivering and they can be excited at being part of a now growing and successful business.

Interestingly my reasons for investing in OO have now changed but next week I will be buying a new business at a new SP level which I consider as v good vfm albeit for now different reasons. From a recovery story to a growth story, and then later perhaps a takeover story. ATB

https://youtu.be/EUWCioFT34Y

Trek

As I read it we are getting paid. There is just an amount outstanding that is/was unpaid. Totally agree with sentiment, driven by a lack of news that’s been driven by a close period, or general hubris with a persistent seller(s) in the mix. The seller may be forced or save just doesn’t fit in, who knows but no TR1’s and AK’s 100 odd meetings have not netted out to insti selling or buying, they’ve held, obviously the sp fall would have been explained and likewise a reason to hold.

The sp has dropped on relatively low volume as often is the case on aim. The UT trades have been small (£1-2k) indicating a relative balance of buys and sell’s. It seems that the seller has a bucket of shares to offload but they are doing it gradually, happy to get rid at this price. Remember it’s the ‘aggressors’ trade that is published, so the trades are matched. In the event of the 3m buy, the sellers broker matched the sale. Sp didn’t move. In the even of the odd 50/25k sells the seller managed to offload whilst there was liquidity. Many of the small buys have I suspect been PI topping up matched by the seller. Obviously all the trades are not the same person but we have been at this level for ages with business slowly being done in 7-8p range. Any volume above 8p and it’s dumped on pegging us back. What a ‘conspiracy’ as no holdings triggered. However, that bucket of stock will empty at some point and hopefully news will arrive to take out any left.

I don’t know about you guys but the cpr feels like a spud and the results feel like TD time. It really shouldn’t be like that as the results are looking back but such is the concern about historic cashflow that buyers seem to be ignoring the cpr and ignoring ak’s reassurances.

I just cant see the results meaning we are suddenly worth say £70m. I personally don’t see that downside. If that were the case I bet a CNOC would agree with me and just tot up the assets and bid or even aiim. It’s really a strange one but worth reminding oneself of ak’s ‘last words’....

Niger...
"I believe that our new Niger Competent Persons Report once again independently verifies the value potential of our asset base in-country.”

Nigeria...
“....In stark contrast Savannah, working closely with our principal customer Niger Delta Power Holding Company (NDPHC) and the Transmission Company of Nigeria (TCN) - who we thank for their strong cooperation - has increased our gas production levels by 34% since completing the acquisition of the Nigerian Assets....”

Now I’m clinging on to the fact that AK can’t sit across a table with insti’s, govt and potential customers, spin all this and then we go under which let’s face it a £78m MCAP is a distressed firesale price. There’s gonna be a light at the end of this one and i’ve been buying.

Trek

This share will be heavily traded for sure. Lots of ups and downs and still massive risks but for those that would like a bit of hyper risk with an upside that is basically incalculable then it’s worth chucking a few bob in here and forgetting about it, hopefully not for another ten years though eh! March next year will do just fine in time for the next ISA decisions.

Trek

107909 from me at the off. Wonder if it was the first one? .03244 pd. nice to Av up!

Trek

Not sure it’s people selling as institutional holders working towards a holding level that they are comfortable with. Unfortunately that means the SP is pegged back to a level that attracts buyers. Remember it’s the ‘aggressors’ trade that is posted and atm that’s the sell but for each sell there is mostly a buyer. News may flip this but for the moment we can but relish this opportunity to add where funds permit. It’s just what the recent holdings RNS’s indicate is happening to the sp atm.

Trek

Only 17 trades, 33 posts and an RNS that tells the market that we can raise hard cash in this climate, $20m vote of confidence and a clear signal that we don’t need to dilute at least for a long time and only then after potentially massive sp inflection points.

Soon hundreds of trades, hundred + posts and a whopper of an RNS. Just a little ‘lateral patience’ required imo.

Trek

Pretty muted market reaction, they need time to absorb it.

The terms are really straightforward.
No CLN’s/SLN’s or warrants the death debt spiral of AIM E&P.
Not dilutive
Tax deductible netting 3.5%
Pay of part of US$ loan
Covenants are fair and when we produce from Coho this will be a ‘small loan’ and terms will be insignificant.
Strengthens negotiations for off take agreements.
I expect the data readout tomorrow, obviously just a coincidence it was ready this way around.
This one wasn’t down to luck it was about nailing an opportunity.
Well done PB.

So please o added two lots yesterday! Nice!

Trek

Personally I think the rns is scrambling. The finance is not nailed on but at least the bod, who now have some decent skin in this, want to avoid dilution. The positives are the nailed drill window, the penalties and that makes a farm in more likely especially now the finance ‘gap’ has been articulated.

Now a farm in would be a great rns.

Trek

Got 43.78. Just a few but powder dry just in case but I really don’t get the SP here. Sure the RNS could have been worded better but it’s all happened before then. It’s like this Co is invisible. Strange.

Trek

Trying to add another tranche on this dip ... NT.

Trek